Back to Search Start Over

What trials do and do not tell us about treatments for severe asthma.

Authors :
Quint JK
Shah PL
Source :
Lancet (London, England) [Lancet] 2024 Jan 20; Vol. 403 (10423), pp. 224-226.
Publication Year :
2024

Abstract

Competing Interests: JKQ has been supported by institutional research grants from the Industrial Strategy Challenge Fund, the Medical Research Council, Health Data Research, GSK, Boehringer Ingelheim, Asthma + Lung UK, and AstraZeneca, and has received personal fees for advisory board participation, consultancy, or speaking fees from GlaxoSmithKline, Evidera, Chiesi, AstraZeneca, and Insmed, unrelated to the topic of this Comment. PLS declares no competing interests.

Details

Language :
English
ISSN :
1474-547X
Volume :
403
Issue :
10423
Database :
MEDLINE
Journal :
Lancet (London, England)
Publication Type :
Academic Journal
Accession number :
38245238
Full Text :
https://doi.org/10.1016/S0140-6736(23)02409-1